Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06704256 · ClinicalTrials.gov registry record

SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery

A clinical trial of Frailty, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06704256: Recruiting study of Frailty, sponsored by Icahn School of Medicine at Mount Sinai.

NCT06704256 is a study of Frailty that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 1,504-participant average among 48 other Frailty trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06704256, a study of Frailty, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This study focuses on evaluating the relationship between physical frailty and measurements of the muscles of the neck in patients undergoing non-cancer Head and Neck surgery.

Primary Outcome

Skeletal muscle derived measures of size of neck skeletal musculature. No maximum or minimum.

Conditions Studied

Study Locations (1)

New York

  • Mount Sinai Hospital - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-28
Est. Completion 2026-10-23

What NCT06704256 shows while recruiting

NCT06704256 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,504-participant average among 48 other Frailty trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 0 interventions.

NCT06704256 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06704256 about?

NCT06704256 is a clinical study titled "SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery". This study focuses on evaluating the relationship between physical frailty and measurements of the muscles of the neck in patients undergoing non-cancer Head and Neck surgery.

What is the current status of trial NCT06704256?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-10-28. Estimated completion is 2026-10-23.

What conditions does trial NCT06704256 study?

This clinical trial studies the following conditions: Frailty.

Who is sponsoring clinical trial NCT06704256?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06704256 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06704256's enrollment target sits among peer trials

100 17th of 48 higher than 28 of 48 other Frailty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06704256, the US trial registry maintained by the National Library of Medicine. NCT06704256 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.